Fully reversible pulmonary arterial hypertension associated with dasatinib treatment for chronic myeloid leukaemia

Eur Respir J. 2011 Jul;38(1):218-20. doi: 10.1183/09031936.00154210.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Blood Pressure
  • Dasatinib
  • Familial Primary Pulmonary Hypertension
  • Hemodynamics
  • Humans
  • Hypertension, Pulmonary / chemically induced*
  • Hypertension, Pulmonary / therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Male
  • Middle Aged
  • Pulmonary Medicine / methods
  • Pyrimidines / adverse effects
  • Pyrimidines / therapeutic use*
  • Thiazoles / adverse effects
  • Thiazoles / therapeutic use*
  • Treatment Outcome
  • Ventricular Dysfunction, Right / complications

Substances

  • Antineoplastic Agents
  • Pyrimidines
  • Thiazoles
  • Dasatinib